0001209191-17-019350.txt : 20170308
0001209191-17-019350.hdr.sgml : 20170308
20170308173303
ACCESSION NUMBER: 0001209191-17-019350
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170306
FILED AS OF DATE: 20170308
DATE AS OF CHANGE: 20170308
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sierra Oncology, Inc.
CENTRAL INDEX KEY: 0001290149
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ? 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
BUSINESS PHONE: 604-558-6536
MAIL ADDRESS:
STREET 1: 2150 ? 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
FORMER COMPANY:
FORMER CONFORMED NAME: ProNAi Therapeutics Inc
DATE OF NAME CHANGE: 20040513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Glover Nicholas
CENTRAL INDEX KEY: 0001578888
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37490
FILM NUMBER: 17676107
MAIL ADDRESS:
STREET 1: C/O PRONAI THERAPEUTICS, INC.
STREET 2: 2150 - 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-03-06
0
0001290149
Sierra Oncology, Inc.
SRRA
0001578888
Glover Nicholas
C/O SIERRA ONCOLOGY, INC.
2150 885 WEST GEORGIA ST.
VANCOUVER
A1
V6C 3E8
BRITISH COLUMBIA, CANADA
1
1
0
0
CEO and President
Stock Option (right to buy)
1.45
2017-03-06
4
A
0
195000
0.00
A
2027-03-06
Common Stock
195000
195000
D
The option vests as to 25% of the total shares on January 1, 2018, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on January 1, 2021, subject to the reporting person's provision of service to the issuer on each vesting date.
/s/ Sukhi Jagpal as attorney-in-fact for Nick Glover, Ph.D.
2017-03-08